Table 2

MAS activity, as defined by physician’s assessment, and laboratory features of MAS before, during and after emapalumab treatment

Screening (n=14)Baseline (n=14)Week 2 (n=14)Week 4 (n=14)Week 8 (n=14)
Physician assessment of MAS activity*, cm, median (range)8.3 (2.0–10.0)8.0 (2.0–10.0)2.3 (0.0–9.5)0.3 (0.0–6.5)0 (0.0–1.0)
Ferritin, ng/mL, median (range)19 865 (367–192 584)25 709 (716–192 584)1410 (65–29 099)180 (22–18 430)55 (4–561)
 Increased, n (%)†13 (93)14 (100)9 (64)2 (14)0 (0)
WBCs, 109/L, median (range)5.8 (1.0–25.7)5.1 (0.9–25.7)8.4 (0.9–32.6)12.3 (2.4–34.7)9.5 (4.8–22.6)
 Decreased, n (%)‡6 (43)7 (50)4 (29)1 (7)1 (7)
Platelets, 109/L, median (range)152 (48–546)112 (52–558)284 (55–590)336 (104–591)383 (214–915)
 Decreased, n (%)‡6 (43)9 (64)4 (29)2 (14)0 (0)
Aspartate aminotransferase, U/L, median (range)244 (26–3814)190 (19–2039)34 (5–146)29 (16–100)28 (15–52)
 Increased, n (%)§12 (86)10 (71)3 (21)1 (7)0 (0)
Alanine aminotransferase, U/L, median (range)190 (139–3179)302 (70–1492)61 (18–327)45 (23–195)28 (7–59)
 Increased, n (%)§14 (100)14 (100)6 (43)5 (35.7)0 (0)
LDH, U/L, median (range)1699 (859–12 734)1502 (588–12 734)518 (283–1572)592 (277–810)497 (306–741)
 Increased, n (%)§13 (100)13 (93)6 (43)4 (29)2 (14)
Fibrinogen, mg/dL, median (range)230 (137–341)174 (70–465)244 (145–515)279 (200–460)337 (190–460)
 Decreased, n (%)¶0 (0)1 (7)0 (0)0 (0)0 (0)
  • *MAS activity was based on a 10 cm visual analogue scale, with scores ranging from 0 to 10 and higher score indicating higher activity.

  • †Increased ferritin was defined as ferritin >684 ng/mL as per 2016 Classification Criteria for MAS complicating sJIA.23

  • ‡Decreased white blood cell and platelet were defined as counts below the lower limit of normal for age of local laboratory.

  • §Increased alanine aminotransferase, aspartate aminotransferase and LDH were defined as values above 1.5 the upper limit of normal range of local laboratory.

  • ¶Decreased fibrinogen was defined as fibrinogen <100 mg/dL.

  • LDH, lactate dehydrogenase; MAS, macrophage activation syndrome; WBC, white blood cells.